Compared with the control, FANCF shRNA significantly enhanced the MX-induced decrease in the cell viability in both cell lines (P<0.05, Fig. 3A), suggesting that known-down of FANCF significantly potentiated the cytotoxic effects of MX on breast cancers. The gene discussed is MX1; the disease is breast carcinoma.